A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200

Clinical trial NCT01564225 · COMPLETED

Trial details

NCT number: NCT01564225
Sponsor: Edimer Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

X-linked Hypohidrotic Ectodermal Dysplasia

Start date: 2012-05-01
Primary completion: 2013-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.